ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$2.55
-0.05 (-1.92%)
Open$2.58
Previous Close$2.60
Day High$2.60
Day Low$2.51
52W High$4.18
52W Low$0.69
Volume—
Avg Volume4.04M
Market Cap641.89M
P/E Ratio—
EPS$-0.54
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+641.6% upside
Current
$2.55
$2.55
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 341.20M | 210.82M | 122.60M |
| Net Income | -53,118,891 | -29,539,669 | 36.77M |
| Profit Margin | -15.6% | -14.8% | 30.0% |
| EBITDA | -38,436 | -22,561 | 61.92M |
| Free Cash Flow | — | — | 30.39M |
| Rev Growth | +61.8% | +61.8% | -8.9% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |